scr-6852
Showing 1 - 1 of 1
Breast Cancer Trial in Shanghai (SCR-6852, Palbociclib)
Recruiting
- Breast Cancer
- SCR-6852
- Palbociclib
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
May 18, 2022